Voyager Therapeutics Inc (VYGR) rating initates by Leerink Partners
Voyager Therapeutics Inc’s filing revealed that its Chief Legal Officer Fahey Sandell Jacquelyn unloaded Company’s shares for reported $34914.0 on
Voyager Therapeutics Inc’s filing revealed that its Chief Legal Officer Fahey Sandell Jacquelyn unloaded Company’s shares for reported $34914.0 on
Voyager Therapeutics Inc’s recent filing unveils that its Chief Legal Officer Fahey Sandell Jacquelyn unloaded Company’s shares for reported $34914.0
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Voyager Therapeutics
In a filing, Voyager Therapeutics Inc revealed its Chief Legal Officer Fahey Sandell Jacquelyn unloaded Company’s shares for reported $34914.0
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Voyager Therapeutics
On January 3, 2024, during the pre-market hours, Voyager Therapeutics, Inc. (VYGR) experienced a noteworthy upswing that grabbed the attention
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.